Claim OwnershipPrognosis: Misconception
Subscribed: 1,018Played: 48,267
Subscribe
2025 iHeartMedia, Inc. © Any use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from iHeartMedia
Description
Reality TV stars are freezing their eggs on camera. Lawmakers in DC are debating federal protection for IVF. Hundreds of millions of dollars are being invested in slick startups that market fertility treatments for all. But this rapid growth has revealed cracks in the system. Misconception, a new series from Bloomberg’s Prognosis, follows reporter Kristen V. Brown on her own intimate journey as she uncovers the business of fertility. Along the way, she finds a fractured industry — a profit-driven field of medicine that thrives on dueling messages of hope and fear as people gamble everything for a chance at a baby.
257 Episodes
Reverse
The Pay Check is collecting stories for our upcoming season, and we want to hear from you! Did having a kid change your career trajectory or the way you work? If you have anything you want to share, call and leave us a voicemail at (212) 617-0166. Stay tuned for more very soon!See omnystudio.com/listener for privacy information.
The Pay Check is back for a second season! For the next six weeks, we’re going to dig into the number one reason women still make less money than men: Motherhood. Women start their careers earning just about the same as men do, but once they have their first kid, that pay gap grows to a chasm. This season, we’ll show you how this “motherhood penalty” plays out for real women, in real life and how it affects the global economy.See omnystudio.com/listener for privacy information.
On this new show from Bloomberg, hosts Mike Regan and Sarah Ponczek speak with expert guests each week about the main themes influencing global markets. They explore everything from stocks to bonds to currencies and commodities, and how each asset class affects trading in the others. Whether you’re a financial professional or just a curious retirement saver, What Goes Up keeps you apprised of the latest buzz on Wall Street and what the wildest movements in markets will mean for your investments. See omnystudio.com/listener for privacy information.
Stephanie Flanders, head of Bloomberg Economics, returns to bring you another season of on-the-ground insight into the forces driving global growth and jobs today. From the cosmetics maker in California grappling with Donald Trump's tariff war, to the coffee vendor in Argentina burdened by the nation's never-ending crises, Bloomberg's 130-plus economic reporters and economists around the world head into the field to tell these stories. Stephanomics will also look hard at the solutions, in the lead-up to Bloomberg’s second New Economy Forum in Beijing, where a select group of business leaders, politicians and thinkers will gather to chart a better course on trade, global governance, climate and more. Stephanomics will help lead the way for those debates not just with Bloomberg journalists but also discussion and analysis from world-renowned experts into the forces that are moving markets and reshaping the world. The new season of Stephanomics launches Oct. 3.See omnystudio.com/listener for privacy information.
Bloomberg's Travel Genius podcast is back! After clocking another hundred-thousand miles in the sky, hosts Nikki Ekstein and Mark Ellwood have a whole new series of flight hacking, restaurant sleuthing, and hotel booking tips to inspire your own getaways—along with a who's who roster of itinerant pros ready to spill their own travel secrets. From a special episode on Disney to a master class on packing, we'll go high, low, east, west, and everywhere in between. The new season starts Nov. 6.See omnystudio.com/listener for privacy information.
Americans are paying more and getting less for their health care than ever before. On the new season of Prognosis, reporter John Tozzi explores what went wrong. See omnystudio.com/listener for privacy information.
We're revisiting some of our favorite episodes, starting with our very first. More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of the pancreas. Now a group of like-minded do-it-yourselfers have gotten together on the internet and—working outside the purview of organized medicine—have figured out how to link a pump, glucose monitor and smartphone to simulate a functioning pancreas. The results have been spectacularly successful.See omnystudio.com/listener for privacy information.
We continue our look back at some of our favorite episodes from the podcast. Do exercise-tracking apps and gadgets like the Fitbit actually make us healthier? Or do they just create a high-tech, data-centric illusion of control over our weight, sleep and general well-being? Bloomberg's Naomi Kresge loaded up some popular apps to find the answer –- and to see if she could get a better night’s sleep than her husband.See omnystudio.com/listener for privacy information.
We continue our look back at some of our favorite episodes from the podcast. Among those most vulnerable to superbug infections are cancer chemotherapy patients. In India, many are dying from bacteria poisoning their blood that even the most potent antibiotics available can't stop. This calamitous scenario portends a global crisis as superbugs spread through international travel and trade.See omnystudio.com/listener for privacy information.
We continue our look back at some of our favorite episodes from the podcast. Joel Grimwood was almost certainly going to die. The pump that kept his failing heart going had become infected, and surgery after surgery had scraped away parts of his chest. Drugs didn’t work because the bacteria were in a slime, impenetrable to antibiotics. What saved his life was a little-known treatment called phage therapy. Popular in the former Soviet Union, they’ve fallen out of favor in the West. The viruses are the natural predator of bacteria, and a small number of scientists are trying to turn them against the threat.See omnystudio.com/listener for privacy information.
From Pushkin Industries, introducing Deep Background with Noah Feldman. Every story has a backstory, even in today's 24-hour news cycle. In Deep Background, Harvard Law School professor and Bloomberg Opinions columnist Noah Feldman will bring together a cross-section of expert guests to explore the historical, scientific, legal, and cultural context that help us understand what's really going on behind the biggest stories in the news.This week, Richard Lazarus, a law professor at Harvard and a leading Supreme Court advocate, discusses where public health stops and our individual liberties begin. Plus, what does it mean that the Supreme Court has postponed oral arguments?Learn more and subscribe to Deep Background on Apple Podcasts, Spotify, or wherever you listen. See omnystudio.com/listener for privacy information.
There’s a growing public health argument about how people should calculate risk when it comes to social distancing. Many states are now lifting stay-at-home restrictions, summer is around the corner, and people in the third month of what many hoped would be a weeks-long disruption are desperate to visit friends and get outside. That means we will be socializing a lot more--in many cases, without clear guidelines as to what’s really risky. Kristen V. Brown reports that as we learn more about how the virus spreads, and what constitutes risky behavior, messaging from experts will have to become a little more nuanced than just “stay home, stay safe.”See omnystudio.com/listener for privacy information.
The killers of Berta Caceres had every reason to believe they’d get away with murder. More than 100 other environmental activists in Honduras had been killed in the previous five years, yet almost no one had been punished for the crimes. Bloomberg’s Blood River follows a four-year quest to find her killers – a twisting trail that leads into the country’s circles of power.Blood River premieres on July 27.See omnystudio.com/listener for privacy information.
More than 150 years after the end of slavery in the U.S., the net worth of a typical white family is nearly six times greater than that of the average Black family. Season 3 of The Pay Check digs into into how we got to where we are today and what can be done to narrow the yawning racial wealth gap in the U.S.Jackie Simmons and Rebecca Greenfield co-host the season, which kicks off with a personal story about land Jackie's family acquired some time after slavery that they're on the verge of losing. From there the series explores all the ways the wealth gaps manifests and the radical solutions, like affirmative action, quotas, and reparations, that can potentially lead to greater equality.See omnystudio.com/listener for privacy information.
A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.See omnystudio.com/listener for privacy information.
On Breakthrough, a new series from the Prognosis podcast, we explore how the pandemic is changing our understanding of healthcare and medicine. We start with an examination of long Covid, a mysterious new illness that has stumped doctors attempting to treat symptoms that last for months and potentially years. It has changed the way hospitals work and forced healthcare officials to prepare for the next pandemic. Covid has also opened the door to revolutionary technology: messenger RNA vaccines. It’s a technology that never could have been proven so quickly outside the crucible of that first pandemic year, 2020, and it holds big implications for the future of medicine. Breakthrough launches on Oct. 19. Subscribe today on Apple Podcasts, Spotify or wherever you get your podcasts.See omnystudio.com/listener for privacy information.
The battle against humanity’s most challenging diseases is happening at the intersection of business and medicine. A new six-episode podcast called Targeting the Toughest Diseases explores how Vertex Pharmaceuticals, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex, the podcast’s latest episode features NBA great Alonzo Mourning recounting his fight against kidney disease, and how future generations of patients may have an easier time of it. You can subscribe today on Apple Podcasts, Spotify or wherever you listen to your favorite podcasts.See omnystudio.com/listener for privacy information.
Hosted by Bloomberg Opinion senior executive editor Tim O'Brien, Crash Course will bring listeners directly into the arenas where epic business and social upheavals occur. Every week, Crash Course will explore the lessons to be learned when creativity and ambition collide with competition and power -- on Wall Street and Main Street, and in Hollywood and Washington.See omnystudio.com/listener for privacy information.
Smoke Screen: Deadly Cure is a podcast about a family on the fringe who convinced tens of thousands of people across the globe to buy a miracle liquid made of poison, the international conspiracy they ignited, and the people who fought to take them down. Smoke Screen: Deadly Cure is a Neon Hum Media, Bloomberg & Sony Music Entertainment production.See omnystudio.com/listener for privacy information.
At Bloomberg, we’re always talking about the biggest business stories, and no one is bigger than Elon Musk. In this new chat weekly show, host David Papadopoulos and a panel of guests including Businessweek’s Max Chafkin, Tesla reporter Dana Hull, Big Tech editor Sarah Frier, and more, will break down the most important stories on Musk and his empire. Listen wherever you get your podcasts.See omnystudio.com/listener for privacy information.
Bloomberg News Now is a comprehensive audio report on today's top stories. Listen for the latest news, whenever you want it, covering global business stories around the world. on Apple: trib.al/Mx9TCh1 on Spotify: trib.al/T4BG8s4 Anywhere: trib.al/O4EX6BA See omnystudio.com/listener for privacy information.
In this limited series, Odd Lots explains some of the thorniest issues facing the US economy through the medium of … chicken. Chicken occupies a unique position in the US diet, but issues facing the poultry industry illustrate wider points about the development of the US economy and the decisions being made about how it's structured and who benefits from it. So why has the chicken industry evolved in the way that it has? What’s been driving the price increases in eggs and meat? And what does it all say about things like inflation, the labor market and the nature of American capitalism? Check out Beak Capitalism on Odd Lots wherever you get your podcasts.See omnystudio.com/listener for privacy information.
Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing to catch up. Prognosis explores the leading edge of medical advances, and asks who gets—or should get—access to them. We look at how innovation happens, when it fails, and what it means to the people with a disease trying to feel better, live longer, or avoid death.See omnystudio.com/listener for privacy information.
More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of the pancreas. Now a group of like-minded do-it-yourselfers have gotten together on the internet and—working outside the purview of organized medicine—have figured out how to link a pump, glucose monitor and smartphone to simulate a functioning pancreas. The results have been spectacularly successful.See omnystudio.com/listener for privacy information.
If you had told people from the 1970s that few decades later the globe would be connected with powerful computers held in the palm of your hand, they could be forgiven for thinking you were seriously deluded. Now, a growing number of scientists are convinced we're on a similar threshold with genetic engineering. Today we'll take you on a tour of a biohacker's DNA experiment to change how frogs—and possibly people—grow muscles. It's an experiment which he insists anyone can try at home. He'll even sell you a kit—frogs included—to do it.See omnystudio.com/listener for privacy information.
In episode three of Prognosis, Kristen V. Brown and Sarah McBride take a trip to Burning Man. They're there to follow Rick Doblin, who has become something of a folk hero for those who believe MDMA—Ecstasy—could be a viable clinical treatment for things like PTSD. But to help push an illegal drug into the mainstream, it takes lots of cash. And to find money for an unconventional treatment, what better place than Burning Man?See omnystudio.com/listener for privacy information.
Eighteen years ago, scientists decoded the human genome. But what was supposed to create an era of new cures didn't work out that way, at least not at first. In episode four of Prognosis, some of the most famous names in genetics explain why it took so long to go from mapping life's code to actually helping people, laying the foundations for technologies on the scientific and ethical cutting edge, like modifying people's genes. See omnystudio.com/listener for privacy information.
Researchers and pharmaceutical companies have poured time and money into developing an effective drug to combat obesity. But time and again, the drugs have failed to deliver. In episode five of Prognosis, Bloomberg's James Paton talks to scientists on the cutting edge of weight-loss research, and the companies that may finally be close to finding a medical solution to the obesity crisis.See omnystudio.com/listener for privacy information.
When you pick up your prescription at the pharmacy, do you ever wonder how that pill made it your way? Who discovered it? Who believed in it when no one else did? Who invested the money to bring it to market? This week on Prognosis, Bloomberg's Rebecca Spalding tells the surprising journey of one life-saving drug, from discovery to market. It's a story about a Nobel Prize winner, cutting edge genetic research, billions of pharmaceutical dollars, and of all things, a worm. What does it tell us about health care in America?See omnystudio.com/listener for privacy information.
Should a patient dying of a disease with no proven cure have the right to try whatever experimental drug they want? A controversial new law signed by President Trump this year says that they should, bypassing the FDA. In episode seven, Bloomberg's Michelle Fay Cortez explores what the new Right To Try law means for desperate patients who want access to experimental treatments. It isn't as simple as it sounds.See omnystudio.com/listener for privacy information.
Some patients can't wait for pharmaceutical companies to develop drugs. They're pushing the drug industry to make the cures they and their loved ones need. But what's good for patients is also good for pharma's profits, creating a web of murky incentives that makes the issue of high drug costs all the more difficult to parse. In episode 8, Bloomberg's Rebecca Spalding talks to these professional patients about their relationships to the big companies whose therapies they need.See omnystudio.com/listener for privacy information.
Prognosis is back for a second season. Over the next few weeks, we're acknowledging how science and technology are making it easier for us to know pretty much everything there is to know about ourselves: Where we come from. The best time to conceive. What might kill us. And what happens when we start getting all that information, and handing it over to others.See omnystudio.com/listener for privacy information.
On the latest edition of Prognosis, we'll tell you how a simple DNA genealogy test upended the life of a Washington state sheep farmer. Instead of finding out more about the Swedish and Jewish roots she'd heard about, she found that she had an entire family she didn't know about, and a connection to a man with a mysterious and controversial past. These types of genetic surprises are getting more common, and redefining who we call family.See omnystudio.com/listener for privacy information.
On this episode of Prognosis, we'll meet the Bloody Health collective – a group of feminist coders in Berlin who are looking for a safer way to track their periods. Targeted advertising, third-party data sharing and tracking make most menstruation apps just as problematic as they are popular, privacy activists argue. For the women of Bloody Health, the sure way to keep control is to build their own open-source app.See omnystudio.com/listener for privacy information.
A century-old quest for family records to unite relatives in heaven has transformed the church into a global leader in genealogy technology. That's paved the way for the success of companies like 23andMe who sell the promise of helping us figure out who are and where we come from.See omnystudio.com/listener for privacy information.
On this episode of Prognosis, reporter Michelle Fay Cortez probes one of the more disturbing unintended consequences of the genetic testing revolution. DNA tests have become so prevalent that more and more people are discovering they have rare and potentially dangerous or even lethal genetic mutations. But how accurate are those findings? And what should people and their doctors do about them? Michelle tells the story of one family faced with the decision whether to proceed with life-altering surgeries to avoid facing a cancer diagnoses one day in the future.See omnystudio.com/listener for privacy information.
On our latest episode of Prognosis, reporter Kristen V. Brown sells her DNA data to the highest bidder. Health data has turned into big business, but Brown quickly realized she wasn’t about to get rich. In exchange for an Amazon gift card or a few shares of marginal value, companies promise to use your data in the quest for better healthcare. See omnystudio.com/listener for privacy information.
By now most of us understand the privacy consequences of all the data we handed over to social media and Internet companies. But what happens to the huge amount of health information we generate from health apps, DNA kits, doctors' visits, blood tests and fitness trackers? Some of it's carefully protected by law. Other data -- including intimate details about our lives -- can be sold to brokers who trade it like a commodity. How worried should we be?See omnystudio.com/listener for privacy information.
Do exercise-tracking apps and gadgets like the Fitbit actually make us healthier? Or do they just create a high-tech, data-centric illusion of control over our weight, sleep and general well-being? Bloomberg's Naomi Kresge loaded up some popular apps to find the answer –- and to see if she could get a better night’s sleep than her husband.See omnystudio.com/listener for privacy information.
Chinese consumers, just like Westerners, are lining up for DNA tests. But unlike their American and European counterparts, the Chinese appear to have far fewer qualms about privacy and sharing their data. And what they’re expecting to glean from their genetic information goes far beyond family trees or hints of future disease. From assessing the talents of hours-old infants to making career and life decisions based on DNA tests, the Chinese have fully embraced the genetics boom. See omnystudio.com/listener for privacy information.
On this new season of Prognosis, we look at the spread of infections that are resistant to antimicrobial medicines. You're probably more likely to have heard of these as superbugs. Their rise has been described as a silent tsunami of catastrophic proportions. We travel to countries on the frontline of the crisis, and explore how hospitals and doctors around the world are fighting back. Prognosis’ new season launches Sept. 5.See omnystudio.com/listener for privacy information.
Among those most vulnerable to superbug infections are cancer chemotherapy patients. In India, many are dying from bacteria poisoning their blood that even the most potent antibiotics available can't stop. This calamitous scenario portends a global crisis as superbugs spread through international travel and trade.See omnystudio.com/listener for privacy information.
Joel Grimwood was almost certainly going to die. The pump that kept his failing heart going had become infected, and surgery after surgery had scraped away parts of his chest. Drugs didn’t work because the bacteria were in a slime, impenetrable to antibiotics. What saved his life was a little-known treatment called phage therapy. Popular in the former Soviet Union, they’ve fallen out of favor in the West. The viruses are the natural predator of bacteria, and a small number of scientists are trying to turn them against the threat.See omnystudio.com/listener for privacy information.
It's no secret that dangerous superbugs are showing up more and more in hospitals around the world. But where do they come from? How do they get into hospitals in the first place? In this episode of Prognosis, Bloomberg's Jason Gale unravels the mystery, taking us on a detective's search for the world's most deadly superbugs as they stealthily sneak into hospitals. And how one hospital has come up with a simple yet virtually foolproof safeguard against spreading those bugs once inside the building. The implications are huge for how hospitals around the world fight back against the spread of killer germs.See omnystudio.com/listener for privacy information.
Many antibiotic pills we’ve relied on for decades to treat infections no longer work. It’s a global crisis. Hospitals are increasingly stumped. But where do resistant bugs come from? In our final episode of this season’s Prognosis, Bloomberg Senior Editor Jason Gale takes us to Copenhagen, Denmark, where one scientist searches for clues in airplane waste from all over the globe. He found killer superbugs thriving in healthy people from countries far and wide. Even in countries where antibiotic use has been strictly controlled, resistant bacteria have made their way to people via the food chain. Yet it’s not too late to turn back See omnystudio.com/listener for privacy information.
In 2020, Americans will spend almost $4 trillion on health care. Yet for all that spending, Americans overall tend to be less healthy and die younger than citizens of other wealthy nations. The cost of health care has become so burdensome that people all across the United States are forced to make difficult choices every day: forgo urgently needed medicines or treatment for serious injuries out of fear the cost, even with insurance, could bankrupt them. How did the U.S. health-care system get this way? And what are some people trying to do to change it? This season’s Prognosis explores these questions. See omnystudio.com/listener for privacy information.
Independent doctors are a vanishing breed. Hospitals have spent decades scooping up physician groups to build large, powerful health-care systems. The rationale was to increase efficiency and save money but often the opposite occurred. In fact, lots of evidence shows that consolidation in health care has driven prices higher. And both physicians and patients increasingly feel that big health systems and insurance companies have too much sway over what happens in the exam room. A few years ago, a group of doctors in Charlotte, North Carolina, decided they’d had enough. They split from the big hospital system that owned their practice to strike out on their own. They’re betting that they can be more competitive, and serve their patients better, independent of their former owners. In this episode of Prognosis, we tell the story of how one doctors’ group bucked the trend toward more concentrated health-care markets, and what it might mean for the future of the U.S. health-care system.See omnystudio.com/listener for privacy information.
In America, poverty is linked to shorter lifespans. The wealthiest 1% of Americans live more than a decade longer than the poorest 1%, and the longevity gap has expanded in recent years. The medical community is increasingly examining the role that poverty and difficult social circumstances play in illness. Some people are asking whether the health care system could do more to address the things that influence people’s health beyond their medical care.This week on Prognosis, we look at one startup that’s trying to redesign care for some of the most vulnerable patients, taking into account the complex realities of their lives. The company is trying to improve care for people and communities the medical system often fails – and it believes that fixing those failures will not only make people healthier, it will also save money.See omnystudio.com/listener for privacy information.
The average cost of having a baby in the United States is $11,000 for people on private health insurance. But the price tag can vary by tens of thousands of dollars, depending on what hospital you go to and what doctor you see. And high-price medical care isn’t necessarily better: In the U.S., regardless of how much they or their insurance company pays, women experience unexpected problems related to pregnancy and childbirth at alarming rates.The problem, of course, isn’t limited to maternity costs. Across the health-care system, wide differences in price and quality for the same procedures have led many economists and policymakers to conclude that the marketplace for medical care is broken. This week on Prognosis, we look at one health plan’s attempt to make it work better. It’s pushing hospitals to improve maternity care while keeping costs in check. These efforts bring to light a lot about what’s wrong with American health care, and one ambitious attempt to fix it.See omnystudio.com/listener for privacy information.
Harnessing Bloomberg's reporting from every continent, Bloomberg's daily Prognosis podcast brings the news, data and analysis you need for living in the time of Covid-19. In around ten minutes, we will explain the latest developments in health and science, the impact on individuals, industries and governments and the adaptions they are making in the face of the global pandemic. Come back every weekday afternoon for a short dose of the best information about the novel coronavirus from more than 120 bureaus around the world. First episode drops Thursday, March 26.See omnystudio.com/listener for privacy information.
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
Download from Google Play
Download from App Store
United States
Thank you for sharing news, information and your investment of time keep us uo to date. you are appreciated.
Good episode